Decorin: a possible marker for fetal growth restriction

dc.contributor.authorCaglar, Mete
dc.contributor.authorYavuzcan, Ali
dc.contributor.authorGoksu, Mehmet
dc.contributor.authorBulbul, Gul Alkan
dc.contributor.authorIsenlik, Bekir Sitki
dc.contributor.authorUstun, Yusuf
dc.contributor.authorKumru, Selahattin
dc.date.accessioned2026-08-12T17:15:20Z
dc.date.issued2014
dc.departmentFırat Üniversitesi
dc.description.abstractThe aim of this study was to compare decorin (DCN) levels between pregnancies complicated by idiopathic fetal growth restriction (FGR) and uncomplicated pregnancies and to determine the relationship between DCN levels and clinical parameters. The study population consisted of two groups: control group consisted of 13 women with uncomplicated singleton pregnancies in the third trimester. Study group consisted of 14 singleton pregnancies complicated by idiopathic FGR who were admitted to the hospital for delivery in the third trimester of pregnancy. Maternal and fetal DCN levels were measured. Color Doppler flow assessments were performed. Relationship between DCN levels and clinical parameters was determined. Maternal DCN serum levels were significantly higher in complicated pregnancies by idiopathic FGR (p = 0.01). A statistically significant negative correlation was observed between maternal DCN serum levels and neonatal birth weight (r = -0.0506; p = 0.007). There was a significant correlation between umbilical artery (UA) DCN levels and UA S/D ratio (r = 0.512; p = 0.006) and UA RI (r = 0.405; p = 0.036). The risk of high DCN maternal serum levels (>7986.6 pg/mL) in pregnancy complicated by FGR was 8.25 times higher (RR = 8.25; 95% CI, 1.4-46.8). The results of our study showed that the presence of increased DCN levels in women with FGR could contribute to pathogenesis of the disease.
dc.identifier.doi10.3109/09513590.2013.860125
dc.identifier.endpage144
dc.identifier.issn0951-3590
dc.identifier.issn1473-0766
dc.identifier.issue2
dc.identifier.orcid0000-0002-1926-4044
dc.identifier.pmid24256371
dc.identifier.scopus2-s2.0-84893029680
dc.identifier.scopusqualityQ2
dc.identifier.startpage141
dc.identifier.urihttps://doi.org/10.3109/09513590.2013.860125
dc.identifier.urihttps://hdl.handle.net/11508/52173
dc.identifier.volume30
dc.identifier.wosWOS:000330586000013
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofGynecological Endocrinology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectAngiogenesis
dc.subjectdecorin
dc.subjectDoppler velocimetry
dc.subjectidiopathic fetal growth restriction
dc.titleDecorin: a possible marker for fetal growth restriction
dc.typeArticle

Dosyalar